Tuesday, October 4, 2022


Biotechnology News Magazine

Algorics Announces Acquisition of Domain Clinical Data Sciences

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

Algorics, a provider of biostatistics and programming solutions for the pharmaceutical and biotechnology industry, today announced the acquisition of Domain Clinical Data Sciences “DCDS”, a clinical data services organization based in India.

The acquisition supports Algorics’ commitment to expanding its team of experienced analytical professionals and sustaining its commercial growth.

Founded in 2013, Algorics specializes in biostatistics, programming, and data standardization solutions for clinical trials. The company supports a global portfolio of biopharmaceutical and CRO clients with cost-effective and high-quality analytical services underpinned by technology know-how and access to high-quality talent in India. Domain Clinical Data Sciences also has a long track record of providing biostatistics and programming support.

The acquisition brings Algorics’ headcount to 60 and expands the company’s geographic footprint with a new location in Hyderabad.

Nithiya Ananthakrishnan, CEO of Algorics, said, “We are delighted to welcome DCDS to the Algorics team. Their strong reputation for clinical biometrics resourcing and their established team of experienced analytical professionals perfectly complement our capabilities. This acquisition represents an important milestone in Algorics’ growth journey and will allow us to increase our scale, strengthen our offering for existing customers, and extend our market reach.”

Vishnu Vardhan, Director of DCDS said, “Algorics has a well-deserved industry reputation for providing exceptional clinical data science solutions, and we are delighted to join them at this exciting point in their expansion. We look forward to continuing to enable our customers’ success as part of the Algorics team.”

The deal builds on 12 months of significant growth for Algorics in which it has brought on board an experienced leadership team, hired new talent, and added new clients to its portfolio.


Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine